DE69515028D1 - Die hocheffiziente herstellung und isolierung von viruspartikeln - Google Patents
Die hocheffiziente herstellung und isolierung von viruspartikelnInfo
- Publication number
- DE69515028D1 DE69515028D1 DE69515028T DE69515028T DE69515028D1 DE 69515028 D1 DE69515028 D1 DE 69515028D1 DE 69515028 T DE69515028 T DE 69515028T DE 69515028 T DE69515028 T DE 69515028T DE 69515028 D1 DE69515028 D1 DE 69515028D1
- Authority
- DE
- Germany
- Prior art keywords
- exchange resin
- insulation
- cells
- highly efficient
- virus particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21583394A | 1994-03-22 | 1994-03-22 | |
PCT/US1995/003668 WO1995025789A1 (en) | 1994-03-22 | 1995-03-22 | Highly efficient production and isolation of viral particles |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69515028D1 true DE69515028D1 (de) | 2000-03-16 |
DE69515028T2 DE69515028T2 (de) | 2000-06-29 |
Family
ID=22804586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69515028T Expired - Fee Related DE69515028T2 (de) | 1994-03-22 | 1995-03-22 | Die hocheffiziente herstellung und isolierung von viruspartikeln |
Country Status (12)
Country | Link |
---|---|
US (2) | US5661023A (de) |
EP (1) | EP0751988B1 (de) |
JP (1) | JP3313117B2 (de) |
AT (1) | ATE189697T1 (de) |
AU (1) | AU2127395A (de) |
CA (1) | CA2186034C (de) |
DE (1) | DE69515028T2 (de) |
DK (1) | DK0751988T3 (de) |
ES (1) | ES2141929T3 (de) |
GR (1) | GR3033268T3 (de) |
PT (1) | PT751988E (de) |
WO (1) | WO1995025789A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2186034C (en) * | 1994-03-22 | 2002-11-26 | Michael E. Hrinda | Highly efficient production and isolation of viral particles |
FR2750433B1 (fr) * | 1996-07-01 | 1998-08-14 | Rhone Poulenc Rorer Sa | Procede de production d'adenovirus recombinants |
US6485958B2 (en) * | 1996-07-01 | 2002-11-26 | Gencell Sa | Method for producing recombinant adenovirus |
ATE348155T1 (de) | 1996-11-20 | 2007-01-15 | Introgen Therapeutics Inc | Ein verbessertes verfahren zur produktion und reinigung von adenoviralen vektoren |
US7732129B1 (en) | 1998-12-01 | 2010-06-08 | Crucell Holland B.V. | Method for the production and purification of adenoviral vectors |
JP2001514845A (ja) * | 1997-09-05 | 2001-09-18 | ターゲティッド ジェネティクス コーポレイション | 組換えaavベクターの高力価ヘルパーなし調製物を生成するための方法 |
AU1956299A (en) * | 1998-01-12 | 1999-07-26 | Her Majesty In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Canada | A process for the isolation, recovery and purification of non-polar extractives |
US6689600B1 (en) | 1998-11-16 | 2004-02-10 | Introgen Therapeutics, Inc. | Formulation of adenovirus for gene therapy |
DE10010342A1 (de) * | 2000-03-06 | 2001-09-20 | Merck Patent Gmbh | Verfahren zur Abreicherung von Endotoxinen |
SE0001132D0 (sv) * | 2000-03-29 | 2000-03-29 | Cavidi Tech Ab | Method of concentrating and recovering a viral enzyme activity from biological samples |
US20040101964A1 (en) * | 2000-05-10 | 2004-05-27 | Shigemitsu Takashima | Method of preparing virus vector |
US20020177571A1 (en) | 2000-11-29 | 2002-11-28 | Gordon Erlinda M. | Targeted vectors for cancer immunotherapy |
ATE425743T1 (de) * | 2001-02-11 | 2009-04-15 | Aquanova Ag | Verfahren zur herstellung eines isoflavon- konzentrats |
US20030031626A1 (en) * | 2001-07-26 | 2003-02-13 | Thomas Rheinlander | Process for the production of pharmaceutical preparations |
DE10137515A1 (de) * | 2001-07-26 | 2003-02-13 | Diagnostikforschung Inst | Verfahren zur Herstellung pharmazeutischer Zubereitungen |
US20070178066A1 (en) * | 2003-04-21 | 2007-08-02 | Hall Frederick L | Pathotropic targeted gene delivery system for cancer and other disorders |
US20090123428A1 (en) * | 2003-04-21 | 2009-05-14 | Hall Frederick L | Pathotropic targeted gene delivery system for cancer and other disorders |
EP2353389B1 (de) * | 2003-04-21 | 2015-11-04 | Epeius Biotechnologies Corporation | Zusammensetzungen zur Behandlung von Erkrankungen |
AU2005305347A1 (en) | 2004-11-03 | 2006-05-18 | Introgen Therapeutics Inc. | Method of producing and purifying of adenoviral vectors |
CN103993040B (zh) | 2008-06-18 | 2018-02-13 | 牛津生物医学(英国)有限公司 | 病毒纯化 |
SG184833A1 (en) | 2010-04-14 | 2012-11-29 | Emd Millipore Corp | Methods of producing high titer, high purity virus stocks and methods of use thereof |
DE102010046817A1 (de) * | 2010-09-28 | 2012-03-29 | Sartorius Stedim Biotech Gmbh | Verfahren zur Abtrennung von Viren aus einem Kontaminanten enthaltenden flüssigen Medium |
CN103476399A (zh) | 2011-04-18 | 2013-12-25 | 独立行政法人国立精神·神经医疗研究中心 | 药剂递送粒子及其制造方法 |
ES2868093T3 (es) | 2012-09-17 | 2021-10-21 | Grace W R & Co | Medio y dispositivos de cromatografía |
CN104768536B (zh) | 2012-09-17 | 2019-03-29 | 格雷斯公司 | 官能化微粒状载体材料和其制备和使用方法 |
US11229896B2 (en) | 2014-01-16 | 2022-01-25 | W.R. Grace & Co.—Conn. | Affinity chromatography media and chromatography devices |
US11389783B2 (en) | 2014-05-02 | 2022-07-19 | W.R. Grace & Co.-Conn. | Functionalized support material and methods of making and using functionalized support material |
ES2896897T3 (es) | 2015-06-05 | 2022-02-28 | Grace W R & Co | Agentes de clarificación para el bioprocesamiento de adsorbentes y métodos para producir y usar los mismos |
WO2019104071A1 (en) | 2017-11-22 | 2019-05-31 | Corning Incorporated | Perfusion bioreactor system and perfusion cell culture method |
US11028124B2 (en) * | 2018-05-07 | 2021-06-08 | Repligen Corporation | Methods, devices and systems for 3-stage filtration |
WO2020214676A1 (en) * | 2019-04-15 | 2020-10-22 | Children's Hospital Medical Center | Viral vector manufacturing methods |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3509070A (en) * | 1968-06-13 | 1970-04-28 | American Home Prod | Adsorbent for chromatographic purification of virus |
US3655509A (en) * | 1969-05-29 | 1972-04-11 | Monsanto Co | Process for the separation of virus from non-viral proteins |
US3925152A (en) * | 1971-06-18 | 1975-12-09 | Exploaterings Ab Tbf | Virus separation |
US4647773A (en) * | 1984-04-23 | 1987-03-03 | The United States Of America As Represented By The Department Of Health And Human Services | Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS |
JPS6147185A (ja) * | 1984-08-09 | 1986-03-07 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスの精製方法 |
JPS6151571A (ja) * | 1984-08-21 | 1986-03-14 | Nippon Seibutsu Kagaku Kenkyusho | オ−エスキ−病診断用抗原の単離・精製法 |
ATE132374T1 (de) * | 1987-06-10 | 1996-01-15 | Immune Response Corp Inc | Verhütung und behandlung einer retrovirenkrankheit |
NZ225583A (en) * | 1987-08-06 | 1991-07-26 | Merck & Co Inc | Process for purifying hepatitis a virions (hav) |
EP0519001B2 (de) * | 1990-03-09 | 2007-12-19 | Novartis Vaccines and Diagnostics, Inc. | Gereinigtes gp120, in dem seine natürliche konformation erhalten bleibt |
FR2661834B1 (fr) * | 1990-05-09 | 1995-01-27 | Merieux Inst | Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus. |
AU650711B2 (en) * | 1990-12-13 | 1994-06-30 | Cellco, Inc. | Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
CA2186034C (en) * | 1994-03-22 | 2002-11-26 | Michael E. Hrinda | Highly efficient production and isolation of viral particles |
JPH08195877A (ja) * | 1995-01-18 | 1996-07-30 | Canon Inc | イメージセンサと画像処理回路 |
-
1995
- 1995-03-22 CA CA002186034A patent/CA2186034C/en not_active Expired - Fee Related
- 1995-03-22 DE DE69515028T patent/DE69515028T2/de not_active Expired - Fee Related
- 1995-03-22 WO PCT/US1995/003668 patent/WO1995025789A1/en active IP Right Grant
- 1995-03-22 JP JP52482495A patent/JP3313117B2/ja not_active Expired - Fee Related
- 1995-03-22 EP EP95914170A patent/EP0751988B1/de not_active Expired - Lifetime
- 1995-03-22 DK DK95914170T patent/DK0751988T3/da active
- 1995-03-22 AU AU21273/95A patent/AU2127395A/en not_active Abandoned
- 1995-03-22 PT PT95914170T patent/PT751988E/pt unknown
- 1995-03-22 AT AT95914170T patent/ATE189697T1/de not_active IP Right Cessation
- 1995-03-22 ES ES95914170T patent/ES2141929T3/es not_active Expired - Lifetime
-
1996
- 1996-03-11 US US08/613,920 patent/US5661023A/en not_active Expired - Fee Related
-
1997
- 1997-04-15 US US08/842,702 patent/US6080571A/en not_active Expired - Fee Related
-
2000
- 2000-04-19 GR GR20000400951T patent/GR3033268T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0751988B1 (de) | 2000-02-09 |
CA2186034A1 (en) | 1995-09-28 |
US5661023A (en) | 1997-08-26 |
EP0751988A4 (de) | 1997-11-12 |
PT751988E (pt) | 2000-05-31 |
CA2186034C (en) | 2002-11-26 |
DK0751988T3 (da) | 2000-06-26 |
JPH10500286A (ja) | 1998-01-13 |
AU2127395A (en) | 1995-10-09 |
US6080571A (en) | 2000-06-27 |
JP3313117B2 (ja) | 2002-08-12 |
ES2141929T3 (es) | 2000-04-01 |
ATE189697T1 (de) | 2000-02-15 |
GR3033268T3 (en) | 2000-09-29 |
DE69515028T2 (de) | 2000-06-29 |
WO1995025789A1 (en) | 1995-09-28 |
EP0751988A1 (de) | 1997-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69515028D1 (de) | Die hocheffiziente herstellung und isolierung von viruspartikeln | |
EP1394259A3 (de) | Rekombinantes infektiöses nicht-in-Segmente-geteiltes negativ-Strange-RNS-Virus | |
AU7007491A (en) | Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses | |
DE69634904D1 (de) | Negativstrand rna virus mit selbständiger replikationsaktivität | |
ATE333501T1 (de) | Methode zur in vitro auseinander- und wiederzusammensetzung von papillomavirus virus- ähnlichen tielchen (vlps) | |
DK0923592T3 (da) | Fremgangsmåder til rensning af nukleinsyrer | |
FR2465508B1 (fr) | Membranes poreuses contenant du polyacrylonitrile modifie, pour l'ultrafiltration, procede de preparation de celles-ci et applications desdites membranes | |
ATE437222T1 (de) | Alphavirus replikon-vektorsysteme | |
EP0863202A4 (de) | Rekombinantes sendai-virus | |
TR199901840T2 (xx) | DNA'nın cross-flow-filtrasyonu ile temizlenmesi. | |
ATE306494T1 (de) | Haemostatisch aktives vwf enthaltendes präparat und verfahren zu seiner herstellung | |
ES2193210T3 (es) | Separacion de virus de soluciones de proteinas por ultrafiltracion. | |
BR9909584A (pt) | Filtração por membrana | |
DE69324645D1 (de) | Verfahren zur Herstellung von Hepatitis Antigenen und Impfstoffen | |
ATE133709T1 (de) | Peroxidase-gen von mikrobischem ursprung | |
DE69103798D1 (de) | Katalysatorsystem und -verfahren zur selektiven Herstellung von Isoprenyl-Alkylethern aus Isopren. | |
DK78990D0 (da) | Fremgangsmaade til rensning af ydre membran protein for haemophilus influenza | |
FI98466B (fi) | FSME-viruksen läntisen alatyypin eristettyjä DNA- ja RNA-molekyylejä, näitä sisältäviä vektoreita ja soluviljelmiä sekä menetelmä näiden koodittamien peptidien valmistamiseksi | |
PT82505A (fr) | Cellules hybrides productrices d'un antigene caracteristique du virus de l'hepatite b obtenu a partir d'hepatocytes et de cellules etablies de singe procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production de l'ant-gene susdit | |
EP0342422A3 (de) | Verfahren zur Herstellung von 2',3'-Dideoxynucleosiden und dabei verwendete neue Zwischenprodukte | |
IT8022031A0 (it) | Processo ed impianto per laproduzione di energia elettrica mediante osmosi attraverso membrane semipermeabili. | |
IT9048611A0 (it) | Processo per la produzione e la purificazione di citocalasina b da phoma exigua var. heteromorpha. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |